Genetics

New antibiotic resistance genes identified in tuberculosis

A massive analysis of more than 10,000 different Mycobacterium tuberculosis bacteria isolates from 23 countries has revealed new genes associated with resistance to 13 first- and second-line new and repurposed antibiotics. ...

Diseases, Conditions, Syndromes

Reviewing molecular tests for tuberculosis

A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, ...

Diseases, Conditions, Syndromes

TB infection rates set to 'turn clock back to 1930s'

During the 1930s, dedicated sanitaria and invasive surgery were commonly prescribed for those with the infection - usually caused by Mycobacterium tuberculosis, which the editors describe as "the most successful human pathogen ...

Medical research

Tracking the spread of tuberculosis in Brazilian prisons

COVID-19 has nothing on tuberculosis. The bacterial infection has ravaged humanity for thousands of years—accounting for one quarter of all deaths in the United States and Europe for 300 years before the discovery of antibiotics.

Diseases, Conditions, Syndromes

Could cod liver oil help combat tuberculosis?

A review of a historical study from 1848 reveals that cod liver oil was an effective treatment for tuberculosis, says Professor Sir Malcolm Green in the Christmas issue published on in the British Medical Journal today.

Diseases, Conditions, Syndromes

Potential new drug for tuberculosis

A new drug capable of inhibiting growth of Mycobacterium tuberculosis is reported this week in Nature Medicine. The findings may improve therapeutic options for the treatment of drug resistant tuberculosis (TB).

Diseases, Conditions, Syndromes

Discovering new drugs to fight TB

(Medical Xpress) -- Research at Victoria University is targeting new drugs to fight drug-resistant and other forms of tuberculosis (TB).

Diseases, Conditions, Syndromes

A 'release and kill' strategy may aid treatment of tuberculosis

Mycobacterium tuberculosis has been called "the perfect pathogen." These bacteria hijack human macrophages, persist inside the cells to evade immune destruction, and then prevent the macrophage from undergoing programmed ...

page 9 from 40